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Abstract
Adolescents, particularly sexual minority youth, account for a disproportionate 
number of sexually transmitted infections and pelvic inflammatory disease cases. 
This population is at increased risk of infection and presents unique challenges 
when it comes to screening and treatment. This chapter will discuss these challenges 
and suggest some evidence based solutions. Challenges to be discussed include lack 
of physician comfort in discussing sexual activity with adolescents, issues of con-
fidentiality, difficulties with contacting adolescent patients with their test results, 
and arranging for treatment of both patients and their partners. A discussion about 
expedited partner therapy will be included—the legal implications and the role it 
plays in sexually transmitted infection reduction efforts.
Keywords: adolescent, young adult, confidentiality, emergency department,  
LGBT, expedited partner therapy
1. Introduction
Adolescents and young adults 15–24 years of age represent approximately 25% 
of the sexually active United States (US) population, but account for nearly half of 
all new sexually transmitted infection (STI) cases [1]. Adolescents have the highest 
incidence of Neisseria gonorrhea and Chlamydia trachomatis among any sexually 
active age group [2]. The most significant complication from STIs is pelvic inflam-
matory disease (PID) with approximately 200,000 adolescents diagnosed annually 
in the US [3]. This population also has an elevated risk of subsequent STIs after 
initial PID, thus putting them at increased risk of associated reproductive health 
sequelae such as infertility, ectopic pregnancy, and chronic abdominal pain  
[4, 5]. Given that adolescents are just entering their reproductive years, STI and PID 
reduction efforts must be maximized.
When it comes to STI reduction efforts in adolescents, a multifactorial approach 
is necessary. It starts with meeting adolescents where they intersect with health care 
professionals (this is not always simply in a physician’s office setting), talking to 
adolescents about sex in a confidential manner, screening appropriately, notifying 
patients with positive results, and treating both the patients and their partners to 
prevent reinfection. This chapter discusses these aspects of tackling STI reduction 
in this age group.
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2. Inherent risk of the adolescent period
Adolescence is a period of rapid physical, social–emotional, and sexual change, 
characterized by experimentation and exploration as one searches to define their own 
identity. For many, sexual debut occurs during adolescence. A number of behavioral, 
biological, and cultural factors among sexually active adolescents and young adults 
lead to higher risk of acquiring an STI in this age group. Biologically, young women 
are more susceptible to STIs because of increased cervical ectopy (which refers to 
columnar cells, usually located within the cervical canal, being located on the outer 
surface of the cervix). These areas of ectopy are fragile with thin, vascularized 
epithelium and thus blood vessels lie in close contact with the vaginal environment; 
possibly diminishing mucosal barriers to sexually transmitted infections.
Beyond biological factors, adolescents are more likely to engage in unprotected 
sex, have multiple sexual partners, and use drugs and alcohol, which may result in 
high risk sexual behaviors [6].
According to the Centers for Disease Control and Prevention (CDC), condom use, 
as reported by sexually active high school students, is inconsistent. Among US high 
school students surveyed in 2017, 46% did not use a condom the last time they had 
sex [6]. Young women are using very effective and long-lasting contraceptive options 
like intrauterine devices and implants at higher rates and should be applauded for 
this, but these offer no protection against STIs such as gonorrhea or chlamydia [6].
Sexual minority youth, identified as lesbian, gay, bisexual, transgender (LGBT), 
represent a subset of the adolescent population at heightened risk for sexually trans-
mitted infections. While many LGBT youth are resilient and thriving, the effects 
of homophobia, heterosexism, and parental rejection may result in psychological 
distress and a subsequent increase in self-destructive risk behaviors [7]. Sexual 
minority youth are more likely to report having intercourse, initiating intercourse at 
younger ages (before age 13), have a greater number of sexual partners (≥4 part-
ners), and are less likely to use barrier contraception compared to heterosexual or 
cis-gender peers [7]. LGBT youth have higher rates of homelessness, which results 
in increased sexual violence and survival sex [7]. Transgender teens (particularly 
male to female transgender youth) have higher rates of HIV and STIs and self-
report lower rates of preventive health checkups and overall poorer health [7, 8].
3. Utilization of health care by adolescents
Utilization of health care by adolescents (LGBT, heterosexual, and cis-gender 
alike) is complicated, and their overall usage of health care is low. Higher rates 
of STIs among adolescents may reflect barriers to accessing preventive care and 
services for sexual and reproductive health. The American Academy of Pediatrics 
(AAP) recommends at least one preventive health visit per year. The data, however, 
show that only 40–80% of adolescents report a primary care visit within 12 months 
[9–11]. A 2010 study of insured adolescents, revealed that one-third had no preven-
tive care visits between the ages of 13 through 17 years, and another 40% had only 
one preventive care visit during this 4 year period of their lives [12]. Barriers in 
accessing care include believing they only need appointments when sick, lack of 
transportation, conflict between school and clinic hours, concerns about confiden-
tiality, lack of health insurance, inability to pay for contraception or STI testing, 
and stigma surrounding accessing STI services [10].
While non-preventive care visits are slightly more frequent among adolescents 
(approximately 1–1.5 visits per year among adolescents age 11 through 17 years), 
a busy practice environment and short encounters with a clinician may not afford 
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the opportunity for full discussions of sexual health, risk taking behaviors, and 
concerns outside of the presenting problem [12]. Nordin and colleagues recommend 
a no-missed-opportunities paradigm, by which all adolescent visits, regardless of 
busy practice environments and short encounters with a clinician, be viewed as 
an opportunity to provide preventive care services [12]. One clinic successfully 
increased the number of preventive health visits for adolescents by “flipping” acute/
sick visits into well-care visits when patients were overdue [13]. Given the dispro-
portionate burden of STIs among adolescents, preventive visits including discus-
sions about sexuality and sexual risk factors are of paramount importance.
The AAP, American Medical Association, and Society for Adolescent Medicine 
recommend that physicians discuss sexuality with youth as part of routine health-
care. Physicians have an important role in helping adolescents develop healthy 
relationships and behaviors. However, when adolescents intersect with healthcare, 
physicians may not feel fully equipped or have the expertise in managing specific 
sexual health needs. The literature suggests that primary care pediatricians are not 
consistent in having important discussions regarding sexuality and sexual risk-
taking behaviors with adolescents [14]. In a survey of AAP members who provide 
health supervision visits to adolescent patients, 58% of pediatricians self-reported 
a lack of interest in adolescent health issues [14]. Perhaps more alarming is the fact 
that <9% of those surveyed were very familiar with AAP policies or CDC recom-
mendations regarding STI and HIV testing for youth [14]. Additionally, 25% of 
providers did not know their own state laws regarding testing of teens for STIs 
without parental consent [14]. While pediatricians believed that reproductive 
health services were an important part of adolescent health care delivery, less than 
half (46%) recommend STI testing for all sexually active teenagers and the vast 
majority (>70%) did not prescribe or distribute condoms, or provide education on 
effective condom use [14].
Given that adolescents are not always consistent with seeing their primary 
physicians for preventive visits, providers need to utilize other opportunities for 
screening for STIs. School-based health centers (SBHCs) are another important 
place where adolescents may access health care. SBHCs remove some of the com-
mon barriers to health care for this age group, including scheduling and transporta-
tion, as the clinics are located where the adolescents already spend their days in 
school. Many of these centers are in urban areas, and they primarily serve high 
schools, alternative schools, or schools with a combination of grade levels [15]. 
Adolescents who use SBHCs have been shown to have more primary care visits 
and fewer emergency department visits than those who do not use these clinics. 
Although SBHCs are sometimes prohibited from dispensing contraceptives by 
school district policy or state law, some are able to provide these services, and they 
also can screen for and treat STIs.
Adolescents also seek care in emergency departments (EDs). The ED has been 
described as a critical “safety net”, treating patients without other sources of care 
[16]. Adolescents make up about 15% of the patient population in the emergency 
department [17, 18]. One study found that 18% of 10–17-year-olds, and 25% of 
18–24-year-olds, had visited an emergency department in the previous year [19]. 
And the rates of STIs found for this patient population in this venue are significant 
[20–23]. PID is the most common diagnosis among adolescents seeking care for 
STIs in US EDs and studies have unfortunately shown incorrect treatment of PID in 
this setting [24, 25].
While the ED is a readily-available place for adolescents to receive health care, 
it poses many challenges, especially given the complex nature of adolescent health 
care. Goyal et al. demonstrated that, in adolescents presenting to the ED with 
genitourinary complaints, the prevalence of STIs was 26% [21]. Schneider et al. 
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found that in adolescents presenting to the ED with non-genitourinary complaints, 
the prevalence of STIs was 10% [22]. Given the nature of emergency care and lack 
of continuity, there is concern that patients testing positive but were not treated 
in the ED may become lost to follow up, and therefore remain untreated [26]. This 
needs to be balanced with antibiotic stewardship and development of antibiotic 
resistant organisms associated with overtreatment [27]. This highlights some of the 
complexities of adolescent STI reduction initiatives in the ED setting.
4. Confidentiality
Where ever they choose to seek care, confidentiality is important to adoles-
cents. Multiple medical and legal organizations recognize the need for providing 
confidential health care to adolescents and a growing body of research has shown 
the importance of this, but this comes with challenges [28–30]. According to the 
Society for Adolescent Medicine, “Confidentiality protection is an essential compo-
nent of health care for adolescents because it is consistent with their development 
of maturity and autonomy and without it, some adolescents will forgo care” [28]. 
A 1997 study by Ford et al. showed that assurances of confidentiality increased the 
number of adolescents willing to return for a future visit to a physician’s office by 
10 percentage points, from 62 to 72% (P = 0.001) [29]. Additionally, adolescents 
who report health risk behaviors have been shown to have an increased likelihood of 
citing confidentiality concerns as a reason for forgone health care [30].
In the United States, each state has legal statues that authorize minors to consent 
for care under a variety of circumstances [31]. Care that minors are allowed to con-
sent for without a parent usually includes contraceptive services, pregnancy-related 
care, diagnosis and treatment of STIs, care related to a sexual assault, treatment for 
drug or alcohol problems, or mental health services. Some states, however, require 
that a minor be of a certain age (generally around 14 years old) before being allowed 
to consent [32].
The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 
creates rights for individuals to have access to their protected health information 
and to control the disclosure of that information in some circumstances. It contains 
specific requirements pertaining to the medical records of minors [33]. The HIPAA 
Privacy Rule provides that, in general, when minors legally consent to health care 
or can receive it without parental consent, the parent does not necessarily have the 
right to access the minor’s health information. This is all dependent, however, on 
each individual state’s laws. Thus, a health care provider must look to state law to 
determine whether it specifically addresses the confidentiality of a minor’s health 
information. If state law is silent on the question of parents’ access, a health care 
professional exercising professional judgment has discretion to determine whether 
or not to grant access [33].
Likely one of the biggest limitations in providing confidential care to adolescents 
has to do with payment. Most often, parents or parents’ health insurance pays for an 
adolescent’s health care. As of the time of publication of this text, there is no legal 
way to prevent a parent from viewing a billing statement and/or explanation of 
benefits (EOBs) from the insurance company. EOBs are notifications to policyhold-
ers that health care services were provided under a health insurance plan, including 
those services provided to any dependents covered by the plan. EOBs generally 
disclose the name and of the provider and the specific laboratory tests used or other 
services rendered. They are intended to protect policyholders and insurers from 
fraud and abuse and to explain financial obligations, but can have unanticipated 
and unintended negative consequences such as a breach of confidentiality [34].
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5. Testing and follow-up
Testing and follow-up are also areas with unique nuances when it comes to 
adolescent patients. Methods for testing and/or screening adolescents for gonor-
rhea and chlamydia include self-obtained vaginal swabs, self-collected urine 
samples, and provider-collected endocervical swabs. For adolescents, the idea of a 
provider-collected specimen can be a barrier to seeking care [35, 36]. Self-collected 
specimens have been shown time and again in the medical literature to be preferred 
by adolescents over provider-collected specimens [37]. Many studies have also 
evaluated the utility of these other forms of testing and have found that the sensi-
tivity and specificity of self-collected swabs and urine samples compared to swabs 
collected by clinicians supports the use of these tests in screening for gonorrhea and 
chlamydia [38, 39].
Given that adolescents do not always present regularly for preventive health 
care visits, the acceptability of and ease of collection with self-collected specimens 
may allow clinicians an opportunity to screen patients in the clinic for STIs who are 
not presenting for pelvic or urogenital examinations and might not otherwise be 
screened as regularly as they should be.
Follow up of adolescents can be problematic, especially for those seeking care 
in emergency departments. ED personnel in one study cited difficulty in reaching 
adolescents and the ease of empiric treatment to justify the practice of empiri-
cally treating STI tested patients and only providing follow-up contact to those 
who tested positive but were not treated at the ED visit [40]. Confirming that 
STI-positive patients receive appropriate treatment is a vital component of any 
screening initiative. Success in contacting adolescents with their results has been 
found, especially when a confidential cell phone number is used [41, 42]. Reed et al. 
worked on increasing the proportion of adolescent patients able to be contacted 
with their test results from 45 to 65% and decreased their lost to follow up rate 
[43]. This was done almost entirely by focusing on making sure that a confidential 
phone number was documented in the electronic medical record. They also gave out 
a card with contact information for a cell phone given to a nurse practitioner who 
was dedicated to contacting and being available for being contacted by the patients 
regarding their results. They learned that adolescents often have cell phone plans 
with limited minutes of talk time, but can still send and receive texts. So while they 
might not answer their phones or check their messages frequently, they will respond 
quickly to a text message.
It is important for adolescents to be aware of their test results, even in the case 
where they have already been empirically treated, as having knowledge about their 
diagnosis can lead to behavior changes [44]. Dr. Reed’s group also followed up, by 
phone, a convenience sample of adolescent women who were empirically treated 
in the ED or teen clinic setting for STI [45]. They found that those who believed 
they had an STI were more likely to abstain from sexual activity and to notify their 
partners. Those who were treated with antibiotics but did not believe they tested 
positive for STIs did not change their behavior.
6. Treatment of adolescents patients and their partners
Treating the partners of STI-positive patients is another important factor in STI 
reduction. Ideally, partners of STI-positive patients would seek health care for eval-
uation, treatment, and counseling in person. This can prove to be a challenge in all 
ages, especially in adolescents and unfortunately, rates of reinfection in adolescents 
and young adults are high. A 2008 study by Gaydos et al. reported up to 26% of 
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adolescent and young adult women were reinfected with their STI within 12 months 
[46]. The AAP has endorsed a position paper by the Society for Adolescent Health 
and Medicine supporting the use of expedited partner therapy (EPT) as a treatment 
option for heterosexual sex partners of adolescents with gonorrhea and chlamydia 
when other partner treatment methods are impractical or unsuccessful [47].
EPT is a management technique in which medications or prescriptions are 
provided for the partner of a patient who tests positive for gonorrhea and/or 
chlamydia without physical examination of that partner. It involves prescribing the 
medication (it is acceptable to write “Expedited Partner Therapy” in place of the 
partner’s name; no date of birth needed). It should also include treatment instruc-
tions, warnings about the medications, general health counseling, and a statement 
that advises the partner to seek medical evaluation in the setting of symptoms.
This technique has proven to be beneficial [48–50]. In a 2005 study by Golden 
et al., EPT was more effective than standard referral of partners in reducing persis-
tent or recurrent infection among patients with gonorrhea (3% vs. 11%, P = 0.01) 
[50]. It is currently not recommended, however, for men who have sex with men or 
women with trichomoniasis because of increased risk of coinfections and lack of 
supporting evidence in these populations.
Optimal STI control requires more than testing and treatment to disrupt trans-
mission; the CDC urges us to counsel these patients on partner treatment and safer 
sex practices. In adolescents especially, communication is key. Talking with adoles-
cents about their risks of reinfection, both surrounding their acute infection as well 
as in the future unless they change their behaviors, is of paramount importance.
7. Conclusion
Adolescents, particularly sexual minority youth, account for a disproportion-
ate number of sexually transmitted infections. Several factors that put adolescents 
at increased risk for STIs have been reviewed here, including high-risk behaviors 
(unprotected sex, sex with multiple partners, increased substance abuse, survival 
sex by homeless LGBT youth) and decreased reproductive and sexual health care 
utilization by teens. Barriers in accessing preventive care and treatment for STIs 
contributes to higher STI rates in this vulnerable population. Despite recommenda-
tions to discuss sexuality and risk behaviors with adolescents, providers may lack 
time, resources and appropriate knowledge surrounding screening guidelines, 
minor consent, and confidentiality to fully meet the needs of adolescent patients. 
A strong STI reduction initiative must place emphasis on the adolescent population 
and its unique attributes and needs.
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